Prevention

Officials from the Los Angeles County Department of Public Health declare a local hepatitis A outbreak, as HAV outbreaks continue in San Diego and Santa Cruz.

Hanneke Schuitemaker, PhD, explains the challenges faced when creating a vaccine for HIV.

Magda Opsomer, MD, shares the results of the Phase 3 EMERALD trial for darunavir.

A fast-paced world requires modern meat inspection processes, but are we lagging in our efforts?

In case you missed them, we've compiled the top 5 articles from this past week.

Following a deadly pneumonia outbreak in a Chinese hospital last year, researchers have identified a dangerous new superbug that is drug-resistant and highly virulent.

William D. O’Riordan, MD, FACEP, explains what makes iclaprim a unique antibiotic.

One single-center study demonstrates that for patients with hospital stays of 1 week or less, reporting bacteriology results sooner may lead to earlier discharge.

David Huang, PhD, MD, explains what the next steps are for iclaprim, an antibiotic developed to treat patients with acute bacterial skin and skin structure infections.

UCLA researchers have shown that using molecular methods to predict susceptibility testing could serve as a new way to monitor drug-resistant gonorrhea.

Researchers from the Moffitt Cancer Center find that the newest HPV vaccine protects against 9 cancer-causing strains of the virus.

Silvia Munoz-Price, MD, PhD, explains how the undefined role of a hospital epidemiologist can be problematic.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Jessica Justman, MD, reveals the latest results of the Population-based HIV Impact Assessment Project (2017).

New CDC Morbidity and Mortality Report highlights gaps in infection control practices in many New York City hospitals.

Administration of the HPV vaccine continues to lag behind that of other recommended vaccines. How can providers increase the proportion of adolescents vaccinated against this sexually transmitted virus?

A FDA expert advisory panel voted unanimously to back a new shingles vaccine developed by GlaxoSmithKline: Shingrix.

Daniel Pilch, PhD, explains how the health care system must change in order to battle antibiotic resistance.

A hepatitis A outbreak rages on in San Diego California, claiming 16 lives thus far.

Antimicrobial stewardship and antimicrobial susceptibility testing (AST) remain critical in the race against antimicrobial resistance.

After being hit with severe flooding and a devastating mudslide, thus increasing risk of cholera infection, half a million individuals in Sierra Leone will now have access to a life-saving vaccine.

Janssen announces a strategic decision to discontinue the development of investigational hepatitis C treatment, JNJ-4178, a triple-combination drug, consisting of three direct-acting antivirals.

Researchers have developed a map of the networks of B-cells in the human body, shedding light on the intricate workings of the immune system.

The CDC has launched an educational initiative called “Get Ahead of Sepsis,” which underscores the early recognition and timely treatment of sepsis.

Milena McLaughlin, PharmD, MSc, explains how officials test if a drug is counterfeit or active.